Refreshing results…
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
Download from www.nature.comAssessing the impact of COVID-19 on liver cancer management (CERO-19)
Download from doi.orgAntibiotic therapy and outcome from immune-checkpoint inhibitors
Download from doi.orgReview article: delivering precision oncology in intermediate-stage liver cancer
Download from hdl.handle.netMissing publications? Search for publications with a matching author name.